Skinvive by JUVÉDERM® represents a distinct category in aesthetic medicine: not a traditional filler that adds volume, not a traditional mesotherapy, but a highly specific injectable skin conditioner designed to improve the intrinsic quality of cheek skin. The result is a smooth, luminous, glassy complexion that patients consistently describe as their skin looking its best version of itself.
At Alpha Medical Limassol, Skinvive is performed by physicians who assess your skin quality, texture and hydration needs individually before treatment. The goal is never to change how you look — it is to reveal the best quality of skin you have.
What Skinvive Does — in Visible Terms
Skinvive is formulated with a uniquely low concentration of cross-linked hyaluronic acid that integrates into the skin rather than sitting beneath it as a volumiser. When injected into the superficial dermis of the cheeks, it dramatically improves skin smoothness and glow — creating what is often described as a glassy, dewy skin quality.
In clinical studies, 96% of participants reported improved skin smoothness at 6 months. The luminosity that results from Skinvive comes from improved light reflection at the skin surface — a consequence of optimised hydration at the level where it matters most.
- Visibly smoother cheek skin — fine surface lines soften significantly
- A glassy, reflective glow that is consistent across all lighting conditions
- Improved skin softness and suppleness to the touch
- Results clinically proven to last up to 6 months after the initial course
- Subtle, natural — no change to facial shape or volume
The Skinvive Treatment at Alpha Medical Limassol
Skinvive is administered through a series of small intradermal injections across the cheek area. The treatment takes around 20–30 minutes in-clinic. JUVÉDERM® Skinvive contains lidocaine for comfort, and most patients find the treatment very well-tolerated.
Our physicians typically recommend an initial course of 2 sessions spaced 4 weeks apart, followed by maintenance at 6 months. Skinvive can be performed as a standalone treatment or as part of a broader skin quality programme — combined with babyGLOW™, NCTF 135, or polynucleotides for a comprehensive regenerative approach.
Skinvive vs. Traditional Skin Boosters
Skinvive occupies a unique position in the injectable landscape. Unlike classic skin boosters which spread more freely through the tissue, Skinvive's specific formulation is designed for cheek treatment and has robust clinical evidence behind it — including a pivotal FDA-approval study demonstrating its durability and smoothing effect.
For patients in Limassol and across Cyprus who are looking for a high-quality, evidence-based skin quality treatment, Skinvive represents a meaningful step forward from older-generation skin boosters.
Ready to take the next step? Book a consultation at our contact page — or request an introductory Medical Aesthetics guide below.
